Literature DB >> 34623330

HIF in the heart: development, metabolism, ischemia, and atherosclerosis.

Andrew Kekūpaʻa Knutson, Allison L Williams, William A Boisvert, Ralph V Shohet.   

Abstract

The heart forms early in development and delivers oxygenated blood to the rest of the embryo. After birth, the heart requires kilograms of ATP each day to support contractility for the circulation. Cardiac metabolism is omnivorous, utilizing multiple substrates and metabolic pathways to produce this energy. Cardiac development, metabolic tuning, and the response to ischemia are all regulated in part by the hypoxia-inducible factors (HIFs), central components of essential signaling pathways that respond to hypoxia. Here we review the actions of HIF1, HIF2, and HIF3 in the heart, from their roles in development and metabolism to their activity in regeneration and preconditioning strategies. We also discuss recent work on the role of HIFs in atherosclerosis, the precipitating cause of myocardial ischemia and the leading cause of death in the developed world.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34623330      PMCID: PMC8409592          DOI: 10.1172/JCI137557

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   19.456


  185 in total

1.  On the AJR viewbox. Monomelic spread of metastatic disease due to proximal deep venous thrombosis.

Authors:  Hans Van der Wall; Amanda Palmer
Journal:  AJR Am J Roentgenol       Date:  2006-06       Impact factor: 3.959

2.  Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse.

Authors:  Masakuni Kido; Lingling Du; Christopher C Sullivan; Xiaodong Li; Reena Deutsch; Stuart W Jamieson; Patricia A Thistlethwaite
Journal:  J Am Coll Cardiol       Date:  2005-11-09       Impact factor: 24.094

3.  HIF-1alpha expression regulates the bactericidal capacity of phagocytes.

Authors:  Carole Peyssonnaux; Vivekanand Datta; Thorsten Cramer; Andrew Doedens; Emmanuel A Theodorakis; Richard L Gallo; Nancy Hurtado-Ziola; Victor Nizet; Randall S Johnson
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

Review 4.  Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles.

Authors:  Michael P Robich; Louis M Chu; Shizu Oyamada; Neel R Sodha; Frank W Sellke
Journal:  Expert Rev Cardiovasc Ther       Date:  2011-11

5.  The protective effect of Hif3a RNA interference and HIF-prolyl hydroxylase inhibition on cardiomyocytes under anoxia-reoxygenation.

Authors:  T Drevytska; E Gonchar; I Okhai; O Lynnyk; I Mankovska; D Klionsky; V Dosenko
Journal:  Life Sci       Date:  2018-04-13       Impact factor: 5.037

6.  Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis.

Authors:  C Ihling; T Szombathy; B Bohrmann; M Brockhaus; H E Schaefer; B M Loeffler
Journal:  Circulation       Date:  2001-08-21       Impact factor: 29.690

7.  Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles.

Authors:  Ming-Lin Liu; Michael P Reilly; Peter Casasanto; Steven E McKenzie; Kevin Jon Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-07       Impact factor: 8.311

8.  Pre- and post-conditional inhibition of prolyl-4-hydroxylase domain enzymes protects the heart from an ischemic insult.

Authors:  Melanie Vogler; Anke Zieseniss; Amke R Hesse; Elif Levent; Malte Tiburcy; Eva Heinze; Nicolai Burzlaff; Gunnar Schley; Kai Uwe Eckardt; Carsten Willam; Dörthe M Katschinski
Journal:  Pflugers Arch       Date:  2015-01-13       Impact factor: 3.657

9.  Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning.

Authors:  Kakali Sarkar; Zheqing Cai; Rigu Gupta; Nirmal Parajuli; Karen Fox-Talbot; Medha S Darshan; Frank J Gonzalez; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-13       Impact factor: 11.205

10.  Essential role of developmentally activated hypoxia-inducible factor 1alpha for cardiac morphogenesis and function.

Authors:  Jaya Krishnan; Preeti Ahuja; Sereina Bodenmann; Don Knapik; Evelyne Perriard; Wilhelm Krek; Jean-Claude Perriard
Journal:  Circ Res       Date:  2008-10-10       Impact factor: 17.367

View more
  10 in total

Review 1.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

2.  Transcriptomic Signatures of End-Stage Human Dilated Cardiomyopathy Hearts with and without Left Ventricular Assist Device Support.

Authors:  Mihir Parikh; Saumya Shah; Ratnadeep Basu; Konrad S Famulski; Daniel Kim; John C Mullen; Philip F Halloran; Gavin Y Oudit
Journal:  Int J Mol Sci       Date:  2022-02-12       Impact factor: 5.923

Review 3.  Cholesterol and HIF-1α: Dangerous Liaisons in Atherosclerosis.

Authors:  Charles Thomas; Damien Leleu; David Masson
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

Review 4.  Noncoding RNAs in the Glycolysis of Ovarian Cancer.

Authors:  Chunmei Zhang; Ning Liu
Journal:  Front Pharmacol       Date:  2022-03-30       Impact factor: 5.810

Review 5.  Emerging roles of extracellular vesicle-associated non-coding RNAs in hypoxia: Insights from cancer, myocardial infarction and ischemic stroke.

Authors:  Dirk M Hermann; Wenqiang Xin; Mathias Bähr; Bernd Giebel; Thorsten R Doeppner
Journal:  Theranostics       Date:  2022-07-18       Impact factor: 11.600

Review 6.  Intermittent Hypoxia and Atherosclerosis: From Molecular Mechanisms to the Therapeutic Treatment.

Authors:  Binyu Luo; Yiwen Li; Mengmeng Zhu; Jing Cui; Yanfei Liu; Yue Liu
Journal:  Oxid Med Cell Longev       Date:  2022-08-03       Impact factor: 7.310

7.  Genome of Laudakia sacra Provides New Insights into High-Altitude Adaptation of Ectotherms.

Authors:  Chaochao Yan; Zhi-Yi Zhang; Yunyun Lv; Zeng Wang; Ke Jiang; Jia-Tang Li
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

Review 8.  HIF in Gastric Cancer: Regulation and Therapeutic Target.

Authors:  Mengqing Li; Guan Li; Xiaodong Yang; Weihua Yin; Guoqing Lv; Shubin Wang
Journal:  Molecules       Date:  2022-07-31       Impact factor: 4.927

9.  Deciphering the combination mechanisms of Gualou-Xiebai herb pair against atherosclerosis by network pharmacology and HPLC-Q-TOF-MS technology.

Authors:  Yarong Liu; Hua Zhong; Pengbo Xu; An Zhou; Lidan Ding; Jingwen Qiu; Hongfei Wu; Min Dai
Journal:  Front Pharmacol       Date:  2022-09-01       Impact factor: 5.988

10.  CircRNA_0050486 promotes cell apoptosis and inflammation by targeting miR-1270 in atherosclerosis.

Authors:  Kai Wang; Xiaolong Bai; Lili Mei; Yanping Miao; Feng Jin
Journal:  Ann Transl Med       Date:  2022-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.